Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunomonitoring in stable kidney transplant recipients on triple immunosuppression
NL-OMON55264Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tacrolimus, mycophenolate mofetil and prednisolone in kidney allograft rejection, sponsored by Centre for Human Drug Research. Primary endpoints: Tacrolimus whole blood concentrations, Mycophenolic acid plasma concentrations and 8 more. Started Nov 2021; status: active, not recruiting.
02
Drugs
tacrolimusmycophenolate mofetilprednisolone
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on NL-OMON55264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55264.